Plasma Neurofilament Light Chain as a Complementary Biomarker for Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline and memory loss, ultimately leading to a loss of independence and reduced quality of life. As current treatments are most effective in the early stages, reliable blood-based biomarkers are required for early diagnosis, therapeut...